Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

22.14
+0.02900.13%
Post-market: 22.140.00000.00%16:10 EDT
Volume:326
Turnover:7K
Market Cap:3.32M
PE:- -
High:22.30
Open:22.30
Low:22.14
Close:22.11
52wk High:24.20
52wk Low:14.40
Shares:150.00K
Float Shares:150.00K
Volume Ratio:0.03
T/O Rate:0.22%
Dividend:0.77
Dividend Rate:3.48%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
3 hours ago

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
5 hours ago

Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis

TradingKey
·
6 hours ago

Moderately bullish activity in Moderna with shares up 8.03%

TIPRANKS
·
6 hours ago

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
7 hours ago

Eli Lilly Stock (LLY) in Focus as Company Completes $3.8 Billion AtaiBeckley Purchase

TIPRANKS
·
Yesterday

Eli Lilly Completes Acquisition of AtaiBeckley

Reuters
·
Yesterday

Lilly Completes Acquisition of Ataibeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Yesterday

Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating

MT Newswires Live
·
Yesterday

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

TIPRANKS
·
Yesterday

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Reuters
·
Yesterday

Growth Without AI: 8 Stock Picks

Dow Jones
·
Yesterday

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Yesterday

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Sep 10

Twist Bioscience Price Target Announced at $45.00/Share by BWS Financial

Dow Jones
·
Sep 10

Moderna Set for 3 Near-Term INT Data Readouts, UBS Says

MT Newswires Live
·
Sep 09

Twist Bioscience initiated with a Sell at BWS Financial

TIPRANKS
·
Sep 09

UBS Initiates Coverage on Twist Bioscience With Neutral Rating, $144 Price Target

MT Newswires Live
·
Sep 09